Popular science

Allanore Y, Khanna D, Smith V, Aringer M, Hoffmann-Vold AM, Kuwana M, Merkel PA, Stock C, Sambevski S, Denton CP, SENSCIS Trial Investigators (2024)
Effects of nintedanib in patients with limited cutaneous systemic sclerosis and interstitial lung disease
Rheumatology (Oxford), 63 (3), 639-647
DOI 10.1093/rheumatology/kead280, PubMed 37294870

Bruni C, Tofani L, Garaiman A, Jordan S, Mihai CM, Dobrota R, Elhai M, Becker MO, Hoffmann-Vold AM, Frauenfelder T, Matucci-Cerinic M, Distler O (2024)
Histogram-Based Densitometry Index to Assess the Severity of Interstitial Lung Disease in Systemic Sclerosis in Standard and Low-Dose Computed Tomography
J Rheumatol, 51 (3), 270-276
DOI 10.3899/jrheum.2023-0415, PubMed 38302169

Del Galdo F, Lescoat A, Conaghan PG, Bertoldo E, Čolić J, Santiago T, Suliman YA, Matucci-Cerinic M, Gabrielli A, Distler O, Hoffmann-Vold AM, Castellví I, Balbir-Gurman A, Vonk M, Ananyeva L, Rednic S, Tarasova A, Ostojic P, Boyadzhieva V, El Aoufy K, Farrington S, Galetti I, Denton CP, Kowal-Bielecka O, Mueller-Ladner U et al. (2024)
EULAR recommendations for the treatment of systemic sclerosis: 2023 update
Ann Rheum Dis (in press)
DOI 10.1136/ard-2024-226430, PubMed 39393843